KvLQT3

KCNQ3
Identifiers
Aliases KCNQ3, BFNC2, EBN2, KV7.3, potassium voltage-gated channel subfamily Q member 3
External IDs OMIM: 602232 MGI: 1336181 HomoloGene: 20949 GeneCards: KCNQ3
Genetically Related Diseases
coronary artery disease[1]
Targeted by Drug
ezogabine, tetraethylammonium[2]
RNA expression pattern
More reference expression data
Orthologs
Species Human Mouse
Entrez

3786

110862

Ensembl

ENSG00000184156

ENSMUSG00000056258

UniProt

O43525

Q8K3F6

RefSeq (mRNA)

NM_001204824
NM_004519

NM_152923

RefSeq (protein)

NP_001191753.1
NP_004510.1

NP_690887.2

Location (UCSC) Chr 8: 132.12 – 132.48 Mb Chr 15: 65.99 – 66.29 Mb
PubMed search [3] [4]
Wikidata
View/Edit HumanView/Edit Mouse

Kv7.3 (KvLQT3) is a potassium channel protein coded for by the gene KCNQ3.[5]

It is associated with benign familial neonatal epilepsy.

The M channel is a slowly activating and deactivating potassium channel that plays a critical role in the regulation of neuronal excitability. The M channel is formed by the association of the protein encoded by this gene and one of two related proteins encoded by the KCNQ2 and KCNQ5 genes, both integral membrane proteins. M channel currents are inhibited by M1 muscarinic acetylcholine receptors and activated by retigabine, a novel anti-convulsant drug. Defects in this gene are a cause of benign familial neonatal convulsions type 2 (BFNC2), also known as epilepsy, benign neonatal type 2 (EBN2).[5]

Interactions

KvLQT3 has been shown to interact with KCNQ5.[6]

References

Further reading

External links

This article incorporates text from the United States National Library of Medicine, which is in the public domain.


This article is issued from Wikipedia - version of the 6/1/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.